Indian drug regulators say Gennova's COVID-19 vaccine safe in early trials
- Country:
- India
Indian pharmaceutical firm Gennova Biopharmaceuticals' mRNA-based COVID-19 vaccine was found to be safe and effective in an early-stage study, the country's drug regulator said on Tuesday.
Health authorities have allowed the company to conduct further studies to test the vaccine's efficacy.
ALSO READ
-
ISRO successfully conducts ground static test of PSLV's third stage at Sriharikota
-
“Rubbing salt into Sikhs’ wounds”: BJP MP Tarun Chugh hits out at Sam Pitroda over 1984 anti-Sikh riots remarks
-
Mahadev betting app case: Accused Saurabh Chandrakar sent to judicial custody till November 19
-
IIT Kharagpur becomes first IIT to introduce NMC-accredited MD programmes
-
Conserve our avian diversity, former Rajasthan CM Vasundhara Raje appeals on National Bird Day
Google News